Synovial sarcoma (SS) is defined by the hallmark SS18-SSX fusion oncoprotein, which renders BAF complexes aberrant in two manners: gain of SSX to the SS18 subunit and concomitant loss of BAF47 subunit assembly. Here we demonstrate that SS18-SSX globally hijacks BAF complexes on chromatin to activate an SS transcriptional signature that we define using primary tumors and cell lines. Specifically, SS18-SSX retargets BAF complexes from enhancers to broad polycomb domains to oppose PRC2-mediated repression and activate bivalent genes. Upon suppression of SS18-SSX, reassembly of BAF47 restores enhancer activation, but is not required for proliferative arrest. These results establish a global hijacking mechanism for SS18-SSX on chromatin, and define the distinct contributions of two concurrent BAF complex perturbations.
Pubmed ID: 29861296 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets ND
View all literature mentionsThis monoclonal targets c-Myc antibody [Y69]
View all literature mentionsThis monoclonal targets Sox2
View all literature mentionsThis isotype control targets not applicable
View all literature mentionsThis monoclonal targets V5-Tag
View all literature mentionsThis polyclonal targets H3K27ac
View all literature mentionsThis polyclonal targets Histone H3, trimethyl (Lys27)
View all literature mentionsThis monoclonal targets Human Histone H3, trimethyl (Lys4)
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis unknown targets ARID1A/BAF250
View all literature mentionsThis monoclonal targets BAF200 (E-3)
View all literature mentionsThis monoclonal targets ARID1A
View all literature mentionsThis polyclonal targets BAF155 (H-76)
View all literature mentionsThis monoclonal targets SMARCB1
View all literature mentionsThis monoclonal targets Pol II
View all literature mentionsThis monoclonal targets V5 Tag
View all literature mentionsThis monoclonal targets ND
View all literature mentionsThis monoclonal targets Sox2
View all literature mentionsThis monoclonal targets c-Myc antibody [Y69]
View all literature mentionsThis isotype control targets not applicable
View all literature mentionsThis monoclonal targets V5-Tag
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis polyclonal targets H3K27ac
View all literature mentionsThis monoclonal targets Human Histone H3, trimethyl (Lys4)
View all literature mentionsThis polyclonal targets Histone H3, trimethyl (Lys27)
View all literature mentionsThis monoclonal targets BAF200 (E-3)
View all literature mentionsThis unknown targets ARID1A/BAF250
View all literature mentionsThis monoclonal targets ARID1A
View all literature mentionsThis polyclonal targets BAF155 (H-76)
View all literature mentionsThis monoclonal targets SMARCB1
View all literature mentions